Ototoxic drugs such as salicylates, the aminoglycoside antibiotics, loop diuretics, cisplatin, erythromycin, and vancomycin are widely used in clinical practice. The most commonly used are aspirin and the aminoglycoside antibiotics. This chapter briefly discusses the pharmacology of the commonly prescribed ototoxic drugs and the doses that may result in ototoxicity. An outline for the monitoring of ototoxic drugs is presented. The role of topical ear drops as a possible cause of ototoxicity is reviewed.
BrummettRETraynorJBrownRHimesDL. Cochlear damage resulting from kanamycin and furosemide. Acta Otolaryngol (Stockh)1975; 80: 86–92.
4.
FeeWEJr. Aminoglycoside ototoxicity in the human. Laryngoscope1980; 90(suppl 24).
5.
SmithCRLipskyJJLaskimDB. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med1980; 302: 1106–9.
6.
SmithCRBaughmanKLEdwardsCQRogersJFLietmanPS. Controlled comparison of amikacin and gentamicin. N Engl J Med1977; 96: 349–53.
7.
LearnerSASeligsohmRRuddRMatzGJ. Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin. Am J Med1977; 62: 919–23.
8.
KahlmeterODahlagerJI. Aminoglycoside toxicity — A review of clinical studies published between 1975 and 1982. J Antimicrob Chemother1984; 13(suppl A): 9–22.
9.
Finitzo-HieberTMcCrackenGHJrBrownKC. Prospective controlled evaluation of auditory functions in neonates given netilmicin or amikacin. J Pediatr1985; 106: 129–36.
10.
KumorKMMcDonaldJMLietmanPS. Effect of “high-dose” amikacin in children. Dev Pharmacol Ther1984; 7: 368–76.
11.
RappaportBZFaustiSASchechterMAFreyRH. A prospective study of high-frequency auditory function in patients receiving oral neomycin. Scand Audiol1986; 15: 67–71.
12.
MorizonoT. Ototopical agents: Ototoxicity in animal studies. Ann Otol Rhinol Laryngol1988; 97(suppl 131): 28–30.
13.
Boston Collaborative Drug Surveillance Program. Drug-induced deafness. JAMA1973; 224: 515–9.
14.
DeerBCHunter-DivarI. Salicylate ototoxicity in the chinchilla: A behavioral and electron microscope study. J Otolaryngol1982; 11: 260–6.
15.
HawkinsJEJr. Ototoxic mechanism — A working hypothesis. Audiology1973; 12: 383–7.
16.
StraussMTowfighiJLordSLiptonAHarveyHABrownB. Cisplatinum ototoxicity: Clinical experience and temporal bone histopathology. Laryngoscope1983; 93: 1554–9.
17.
KrobothPDMcNielMAKreegerADominguezJRaultR. Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysis. Arch Intern Med1983; 143: 1263–6.
18.
RybakLPBoickeSC. Additive toxicity in patients receiving vancomycin and aminoglycosides. Clin Pharm1983; 2: 508–11.
19.
RybakLPMatzGJ. Ototoxicity. In: RubinRAlbertoP, eds. Otologic medicine and surgery. New York, NY: Churchill Livingstone, 1988: 1623–35.
